{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:51:28Z","timestamp":1779889888547,"version":"3.53.1"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T00:00:00Z","timestamp":1421280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>\u2003<\/jats:title>\n                  <jats:p>Combining antiresorptive and anabolic drugs for osteoporosis may be a useful strategy to prevent hip fractures. Previous studies comparing the effects of alendronate (ALN) and teriparatide (TPTD) alone, combined or sequentially using quantitative computed tomography (QCT) in postmenopausal women have not distinguished cortical bone mineral density (CBMD) from cortical thickness (CTh) effects, nor assessed the distribution and extent of more localized changes. In this study a validated bone mapping technique was used to examine the cortical and endocortical trabecular changes in the proximal femur resulting from an 18-month course of ALN or TPTD. Using QCT data from a different clinical trial, the global and localized changes seen following a switch to TPTD after an 18-month ALN treatment or adding TPTD to the ALN treatment were compared. Ct.Th increased (4.8%, p\u2009&amp;lt;\u20090.01) and CBMD decreased (\u22124.5%, p\u2009&amp;lt;\u20090.01) in the TPTD group compared to no significant change in the ALN group. A large Ct.Th increase could be seen for the switch group (2.8%, p\u2009&amp;lt;\u20090.01) compared to a significantly smaller increase for the add group (1.5%, p\u2009&amp;lt;\u20090.01). CBMD decreased significantly for the switch group (\u20133.9%, p\u2009&amp;lt;\u20090.01) and was significantly different from no significant change in the add group. Ct.Th increases were shown to be significantly greater for the switch group compared to the add group at the load bearing regions. This study provides new insights into the effects of ALN and TPTD combination therapies on the cortex of the proximal femur and supports the hypothesis of an increased bone remodeling by TPTD being mitigated by ALN. \u00a9 2014 American Society for Bone and Mineral Research.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/jbmr.2454","type":"journal-article","created":{"date-parts":[[2015,1,15]],"date-time":"2015-01-15T14:15:42Z","timestamp":1421331342000},"page":"1309-1318","source":"Crossref","is-referenced-by-count":27,"title":["Mapping Bone Changes at the Proximal Femoral Cortex of Postmenopausal Women in Response to Alendronate and Teriparatide Alone, Combined or Sequentially"],"prefix":"10.1093","volume":"30","author":[{"given":"Tristan","family":"Whitmarsh","sequence":"first","affiliation":[{"name":"Department of EngineeringUniversity of CambridgeCambridgeUK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham M","family":"Treece","sequence":"additional","affiliation":[{"name":"Department of EngineeringUniversity of CambridgeCambridgeUK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H","family":"Gee","sequence":"additional","affiliation":[{"name":"Department of EngineeringUniversity of CambridgeCambridgeUK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth ES","family":"Poole","sequence":"additional","affiliation":[{"name":"Department of MedicineUniversity of CambridgeCambridgeUK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,1,15]]},"reference":[{"issue":"6","key":"2024020319043333700_jbmr2454-bib-0001","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1001\/jama.285.6.785","volume":"285","author":"NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy","year":"2001","journal-title":"JAMA."},{"issue":"19","key":"2024020319043333700_jbmr2454-bib-0002","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med."},{"issue":"7","key":"2024020319043333700_jbmr2454-bib-0003","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2003-1703","article-title":"Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy","volume":"90","author":"Dobnig","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2024020319043333700_jbmr2454-bib-0004","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1359\/jbmr.070104","article-title":"Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium","volume":"22","author":"Lindsay","year":"2007","journal-title":"J Bone Miner Res."},{"issue":"3","key":"2024020319043333700_jbmr2454-bib-0005","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bone.2010.05.022","article-title":"Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-month, randomized, placebo-controlled, double-blind and 12-month open-label phases","volume":"47","author":"Miyauchi","year":"2010","journal-title":"Bone."},{"issue":"3","key":"2024020319043333700_jbmr2454-bib-0006","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1359\/JBMR.051109","article-title":"A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide","volume":"21","author":"Lindsay","year":"2006","journal-title":"J Bone Miner Res."},{"issue":"3","key":"2024020319043333700_jbmr2454-bib-0007","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1210\/jc.2002-021988","article-title":"Effects of intermittent parathyroid hormone administration on bone mineralization density in iliac crest biopsies from patients with osteoporosis: a paired study before and after treatment","volume":"88","author":"Misof","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2024020319043333700_jbmr2454-bib-0008","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1359\/JBMR.050309","article-title":"Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters","volume":"20","author":"Arlot","year":"2005","journal-title":"J Bone Miner Res."},{"issue":"5","key":"2024020319043333700_jbmr2454-bib-0009","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S8756-3282(00)00376-8","article-title":"Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women","volume":"27","author":"Boivin","year":"2000","journal-title":"Bone."},{"issue":"2","key":"2024020319043333700_jbmr2454-bib-0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S8756-3282(01)00485-9","article-title":"Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women","volume":"29","author":"Roschger","year":"2001","journal-title":"Bone."},{"issue":"4","key":"2024020319043333700_jbmr2454-bib-0011","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1210\/jc.2009-1703","article-title":"Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis","volume":"95","author":"Finkelstein","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"20","key":"2024020319043333700_jbmr2454-bib-0012","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","article-title":"Teriparatide or alendronate in glucocorticoid-induced osteoporosis","volume":"357","author":"Saag","year":"2007","journal-title":"N Engl J Med."},{"issue":"11","key":"2024020319043333700_jbmr2454-bib-0013","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1002\/art.24879","article-title":"Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial","volume":"60","author":"Saag","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"3","key":"2024020319043333700_jbmr2454-bib-0014","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01926230252929882","article-title":"Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety","volume":"30","author":"Vahle","year":"2002","journal-title":"Toxicol Pathol."},{"issue":"4","key":"2024020319043333700_jbmr2454-bib-0015","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/01926230490462138","article-title":"Bone neoplasms in F344 rats given teriparatide rhPTH(1-34). are dependent on duration of treatment and dose","volume":"32","author":"Vahle","year":"2004","journal-title":"Toxicol Pathol."},{"key":"2024020319043333700_jbmr2454-bib-0016","year":"2011"},{"issue":"10","key":"2024020319043333700_jbmr2454-bib-0017","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1210\/jc.2008-2719","article-title":"Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: differences between stopping and continuing the antiresorptive agent","volume":"94","author":"Cosman","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2024020319043333700_jbmr2454-bib-0018","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/jbmr.1853","article-title":"Hip and spine strength effects of adding versus switching to teriparatide in postmenopausal women with osteoporosis treated with prior alendronate or raloxifene","volume":"28","author":"Cosman","year":"2013","journal-title":"J Bone Miner Res."},{"issue":"5","key":"2024020319043333700_jbmr2454-bib-0019","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1359\/jbmr.040117","article-title":"Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate","volume":"19","author":"Ettinger","year":"2004","journal-title":"J Bone Miner Res."},{"issue":"10","key":"2024020319043333700_jbmr2454-bib-0020","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1210\/jc.2008-0353","article-title":"Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate","volume":"93","author":"Miller","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2024020319043333700_jbmr2454-bib-0021","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1359\/jbmr.080506","article-title":"Effects of two years of daily teriparatide treatment on BMD in postmenopausal women with severe osteoporosis with and without prior antiresorptive treatment","volume":"23","author":"Obermayer-Pietsch","year":"2008","journal-title":"J Bone Miner Res."},{"issue":"13","key":"2024020319043333700_jbmr2454-bib-0022","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa031975","article-title":"The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis","volume":"349","author":"Black","year":"2003","journal-title":"N Engl J Med."},{"issue":"6","key":"2024020319043333700_jbmr2454-bib-0023","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1056\/NEJMoa050157","article-title":"Daily and cyclic parathyroid hormone in women receiving alendronate","volume":"353","author":"Cosman","year":"2005","journal-title":"N Engl J Med."},{"issue":"3","key":"2024020319043333700_jbmr2454-bib-0024","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.media.2010.01.003","article-title":"High resolution cortical bone thickness measurement from clinical CT data","volume":"14","author":"Treece","year":"2010","journal-title":"Med Image Anal."},{"issue":"5\u20134","key":"2024020319043333700_jbmr2454-bib-0025","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.media.2012.02.008","article-title":"Imaging the femoral cortex: thickness, density and mass from clinical CT","volume":"16","author":"Treece","year":"2012","journal-title":"Med Image Anal. Jul."},{"issue":"1","key":"2024020319043333700_jbmr2454-bib-0026","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.media.2014.11.012","article-title":"Independent measurement of femoral cortical thickness and cortical bone density using clinical CT","volume":"20","author":"Treece","year":"2015","journal-title":"Med Image Anal."},{"issue":"15","key":"2024020319043333700_jbmr2454-bib-0027","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1001\/archinte.165.15.1762","article-title":"Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass","volume":"165","author":"McClung","year":"2005","journal-title":"Arch Intern Med."},{"issue":"1","key":"2024020319043333700_jbmr2454-bib-0028","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/jbmr.2325","article-title":"Denosumab rapidly increases cortical bone in key locations of the femur: a 3D bone mapping study in women with osteoporosis","volume":"30","author":"Poole","year":"2015","journal-title":"J Bone Miner Res."},{"key":"2024020319043333700_jbmr2454-bib-0029","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1016\/S1053-8119(09)70882-1","article-title":"Surfstat: a MATLAB toolbox for the statistical analysis of univariate and multivariate surface and volumetric data using linear mixed effects models and random field theory","author":"Worsley","year":"2009","journal-title":"Neuroimage."},{"issue":"3","key":"2024020319043333700_jbmr2454-bib-0030","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1359\/jbmr.090820","article-title":"Quantitative computed tomographic assessment of the effects of 24 months of teriparatide treatment on 3D femoral neck bone distribution, geometry, and bone strength: results from the EUROFORS study","volume":"25","author":"Borggrefe","year":"2010","journal-title":"J Bone Miner Res."},{"issue":"3","key":"2024020319043333700_jbmr2454-bib-0031","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00198-013-2596-y","article-title":"The effects of once-weekly teriparatide on hip structure and biomechanical properties assessed by CT","volume":"25","author":"Ito","year":"2014","journal-title":"Osteoporos Int."},{"key":"2024020319043333700_jbmr2454-bib-0032","doi-asserted-by":"crossref","first-page":"e16190","DOI":"10.1371\/journal.pone.0016190","article-title":"Targeted regeneration of bone in the osteoporotic human femur","author":"Poole","year":"2011","journal-title":"PLoS One."},{"issue":"6","key":"2024020319043333700_jbmr2454-bib-0033","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1359\/jbmr.060314","article-title":"Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis","volume":"21","author":"Ma","year":"2006","journal-title":"J Bone Miner Res."},{"issue":"1","key":"2024020319043333700_jbmr2454-bib-0034","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jbmr.2315","article-title":"Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT Study","volume":"30","author":"Tsai","year":"2015","journal-title":"J Bone Miner Res."},{"issue":"7","key":"2024020319043333700_jbmr2454-bib-0035","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1210\/jc.2014-1041","article-title":"Teriparatide increases strength of the peripheral skeleton in premenopausal women with idiopathic osteoporosis: a pilot HR-pQCT study","volume":"99","author":"Nishiyama","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2024020319043333700_jbmr2454-bib-0036","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1359\/jbmr.2001.16.10.1846","article-title":"Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study","volume":"16","author":"Dempster","year":"2001","journal-title":"J Bone Miner Res."},{"issue":"11","key":"2024020319043333700_jbmr2454-bib-0037","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1359\/jbmr.2003.18.11.1932","article-title":"Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure","volume":"18","author":"Jiang","year":"2003","journal-title":"J Bone Miner Res."},{"issue":"11","key":"2024020319043333700_jbmr2454-bib-0038","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1002\/jbmr.198","article-title":"Effects of 1 year of daily teriparatide treatment on iliacal bone mineralization density distribution (BMDD) in postmenopausal osteoporotic women previously treated with alendronate or risedronate","volume":"25","author":"Misof","year":"2010","journal-title":"J Bone Miner Res."},{"issue":"3","key":"2024020319043333700_jbmr2454-bib-0039","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1210\/jc.2007-0711","article-title":"EUROFORS Investigators. Effects of previous antiresorptive therapy on the bone mineral density response to two years of teriparatide treatment in postmenopausal women with osteoporosis","volume":"93","author":"Boonen","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2024020319043333700_jbmr2454-bib-0040","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.bone.2009.11.032","article-title":"Time sequence of secondary mineralization and microhardness in cortical and cancellous bone from ewes","volume":"46","author":"Bala","year":"2010","journal-title":"Bone."},{"issue":"6","key":"2024020319043333700_jbmr2454-bib-0041","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa050336","article-title":"One year of alendronate after one year of parathyroid hormone (184) for osteoporosis","volume":"353","author":"Black","year":"2005","journal-title":"N Engl J Med."},{"issue":"8","key":"2024020319043333700_jbmr2454-bib-0042","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/jbmr.2216","article-title":"Overlapping and continued alendronate or raloxifene administration in patients on teriparatide: effects on areal and volumetric bone mineral density\u2014The CONFORS Study","volume":"29","author":"Muschitz","year":"2014","journal-title":"J Bone Miner Res."},{"issue":"1","key":"2024020319043333700_jbmr2454-bib-0043","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00198-002-1301-3","article-title":"A comprehensive review of treatments for postmenopausal osteoporosis","volume":"14","author":"H\u00e4uselmann","year":"2003","journal-title":"Osteoporos Int."},{"key":"2024020319043333700_jbmr2454-bib-0044","doi-asserted-by":"crossref","first-page":"e38466","DOI":"10.1371\/journal.pone.0038466","article-title":"Cortical thickness mapping to identify focal osteoporosis in patients with hip fracture","volume":"(6)","author":"Poole","year":"2012","journal-title":"PLoS One."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.2454","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/30\/7\/1309\/56567434\/jbmr2454.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/30\/7\/1309\/56567434\/jbmr2454.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T14:53:44Z","timestamp":1710341624000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/30\/7\/1309-1318\/7599160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,15]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,1,15]]},"published-print":{"date-parts":[[2015,7,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.2454","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,7,1]]},"published":{"date-parts":[[2015,1,15]]}}}